CS
CHTP

Credit Suisse’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Credit Suisse’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-146,715
Closed -$809K – 4966
2014
Q1 		$809K Buy
146,715
+9,146
+7% +$45.9K ﹤0.01% 3312
2013
Q4 		$610K Buy
137,569
+64,592
+89% +$218K ﹤0.01% 3644
2013
Q3 		$219K Buy
72,977
+59,733
+451% +$172K ﹤0.01% 3930
2013
Q2 		$30K Buy
+13,244
New +$26.8K ﹤0.01% 4129

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Credit Suisse's CHTP Position: Q2 2014 in Review

Credit Suisse sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 146,715 shares — an estimated $809K sold.

Credit Suisse first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $809K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Credit Suisse reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Credit Suisse sold 146,715 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $809K.
  • Credit Suisse first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Credit Suisse's CHELSEA THERAPEUTICS INT'L LTD position peaked at $809K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.